Biomm S.A. (BOVESPA: BIOM3)
Health Care · Biotechnology · BR
R$7.34
+13.80% today · -26.6% 1Y
Biomm S.A. (BOVESPA: BIOM3) operates in the Biotechnology industry within the Health Care sector. The company is valued at $201.65M and employs 130 people.
Over the last twelve months the share price has lost 26.6%, trading between 4.82 and 10.30.
Tweenvest scores Biomm S.A. across four factors: quality 37/100, value 44/100, growth 100/100. Its strongest factor is growth.
BIOM3 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $201.65M
- Revenue (TTM)
- $74.20M
- P/E
- 33.15
- EPS
- 0.22
- Dividend yield
- —
- Beta (5Y)
- 0.49
- 52-week high
- R$10.30
- 52-week low
- R$4.82
- Avg volume (3M)
- —
- Shares outstanding
- 136.85M
- Employees
- 130
- Next earnings
- —
About Biomm S.A.
Biomm S.A. is a biotechnology enterprise based in Brazil. Its diverse product portfolio features pharmaceutical and healthcare solutions, including AFREZZA, a human insulin administered as an inhalation powder, and GLARGILIN, a type of glargine insulin. The company also supplies HERZUMA, a trastuzumab, and CONFORT CARE, a moisturizing foot cream. Biomm S.A. was established in 2001 and maintains its headquarters in São Paulo, Brazil.
- ISIN
- BRBIOMACNOR2
- Founded
- 2001
- Listed since
- Jan 11, 2000
- Exchange
- Bolsa de Valores de Sao Paulo
- Currency
- BRL
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Japan Tissue Engineering Co., Ltd.TSE: 7774 | $203.38M | ¥793.00 | -4.80% |
| SinoMab BioScience LimitedSEHK: 3681 | $203.20M | HK$1.15 | +13.86% |
| Compugen Ltd.NasdaqCM: CGEN | $201.76M | $2.11 | -0.94% |
| Eledon Pharmaceuticals, Inc.NasdaqCM: ELDN | $201.73M | $2.28 | -8.27% |
| Whitehawk Therapeutics, Inc.NasdaqCM: WHWK | $200.67M | $3.07 | -12.78% |
| S.Biomedics Co., Ltd.KOSDAQ: A304360 | $200.37M | ₩21,750.00 | +4.07% |
| Alpha Cognition Inc.NasdaqCM: ACOG | $196.87M | $8.60 | -4.87% |
| Thor Medical ASAOB: TRMED | $196.75M | Nkr4.46 | -1.00% |
Figures last refreshed Oct 11, 2026.